Efficacy of adalimumab combined with Tripterygium wilfordii Hook F in the treatment of patient with rheumatoid arthritis: A multicenter, open ‐label, randomized‐controlled trial

ConclusionsThere were no significant differences in efficacy and safety between ADA combined with TwHF versus ADA combined with MTX in the treatment of RA. TwHF might be an alternative treatment for RA patients who are intolerant to MTX.

Source: International Journal of Rheumatic Diseases - January 24, 2024 Category: Rheumatology Authors: Feng Luo, Shuo ‐Yan Gau, Yu‐xia Wu, Hou‐li Liao, Fang Tang, Qin Zhong, Ying Huang, Lei Hou, Zheng‐qi Liu, Jin‐long Cai, Yue‐peng Cao, Dao‐min Lu, Yang An, Wei‐ya Lan, Can Liu, Chang‐ming Chen, Er‐tao Jia, Xue‐ming Ya Tags: ORIGINAL ARTICLE Source Type: research